Libya vs Republic of Moldova: Women's share of population ages 15+ living with HIV
Libya
40.1%
in 2024
Republic of Moldova
39.1%
in 2024
Libya rank
71st
Republic of Moldova rank
74th
Women's share of population ages 15+ living with HIV over time
- Libya
- Republic of Moldova
How they compare
Libya currently reports 40.1% against 39.1% in Republic of Moldova, a difference of 1.0%.
Across all 35 years both countries report, Libya has been ahead every year.
Libya ranks 71st and Republic of Moldova ranks 74th of 172 countries.
Libya has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Libya | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 33.2% | 29.2% | 4.0% | Libya |
| 2000s | 37.7% | 31.7% | 6.0% | Libya |
| 2010s | 38.9% | 34.4% | 4.5% | Libya |
| 2020s | 39.7% | 38.1% | 1.5% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher women's share of population ages 15+ living with hiv, Libya or Republic of Moldova?
- Libya, at 40.1% against 39.1% in Republic of Moldova as of 2024.
- What is the difference in women's share of population ages 15+ living with hiv between Libya and Republic of Moldova?
- 1.0%, with Libya ahead.
- How many years of comparable data are there for Libya and Republic of Moldova?
- 35 years are reported by both, from 1990 to 2024.
- How do Libya and Republic of Moldova rank globally for women's share of population ages 15+ living with hiv?
- Libya ranks 71st and Republic of Moldova ranks 74th of 172 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Women's share of population ages 15+ living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.